Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Curr Trends Microbiol. 2018;12:95–107.

Table 1.

Clinical characteristics of MRSA-VAP patients compared with those with VAP due to other microorganisms

Demographic MRSA-VAP Non-MRSA-VAP P-value
Age 68 (59–74) 62 (44–73) 0.03
Antibiotic treatment 92 (82.9%) 234 (64.5%) <0.001
Abdominal surgery 39 (35.1%) 70 (19.3%) <0.001
Presurgical antibiotic prophylaxis 43 (38.7%) 87 (24%) 0.003